Meet the Visionary Team Behind Psycheceutical
Our mission at Psycheceutical is to develop, improve, and commercialize cutting-edge delivery technologies that can be used across the mental health treatment spectrum while providing safe and effective delivery of psychedelic pharmaceutical medicines.Meet The Team
FDA Drug Development Veterans
Our team of industry experts has 100+ years of combined experience in psychedelics, biotechnology, and business development across the pharmaceutical industry.
Savvy Technologists and Mental Health Science Experts
Our visionary founders are considered among the top minds in the psychedelic space, embracing the latest technologies to further the advancement of mental health science.
State-of-the-Art Biotech Solutions
Our groundbreaking Janus particle solution and NeuroDirect™ delivery system allow psychedelic compounds to be administered without unwanted side effects and toxicity.
Click to read each team member’s bio
Brand Awareness Team
Founded by Dr. Anish Dhanarajan, PhD and Francesca Minale, MEng in 2016, Vici is a world-class pharmaceutical product development company working hard to identify unmet pharmaceutical needs that can be solved by drug development through the 505(b)(2) NDA or ANDA pathway.
In pursuit of this goal, Vici operates a rapid, low-cost, high quality prototyping R&D facility capable of GMP operations in Maryland, USA, and is an end-to-end pharmaceutical R&D company capable of taking projects from inception through FDA approval.